The work carried out by TransferTech Sherbrooke (TTS) enabled the French investment company Erganeo, which specializes in breakthrough innovations (DeepTech) with a strong societal impact, to sign an exclusive worldwide sub-licence with the start-up Orixha on June 17. The signing of this license will allow Orixha to further develop this innovative technology to create a medical device to protect the heart, brain and vital organs of people suffering from cardiac arrest.
It was following the commercialization mandate signed in 2016 between TTS and Erganeo that the latter was able to obtain the exploitation rights to commercialize this invention resulting from the research work of the Université de Sherbrooke.
TTS is proud to announce the signing of this license and wishes Erganeo and Orixha great success in the development and commercialization of this new product.
To read Erganeo’s press release, in French only: https://www.erganeo.com/licence-erganeo-orixha